KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShort-Term Debt issuances
Ratios

Amneal Pharmaceuticals (AMRX) Receivables Refunds (2018 - 2019)

Historic Receivables Refunds for Amneal Pharmaceuticals (AMRX) over the last 2 years, with Q4 2019 value amounting to $13.7 million.

  • Amneal Pharmaceuticals' Receivables Refunds fell 5362.03% to $13.7 million in Q4 2019 from the same period last year, while for Dec 2019 it was $13.7 million, marking a year-over-year decrease of 5362.03%. This contributed to the annual value of $13.7 million for FY2019, which is 5362.03% down from last year.
  • Latest data reveals that Amneal Pharmaceuticals reported Receivables Refunds of $13.7 million as of Q4 2019, which was down 5362.03% from $29.6 million recorded in Q4 2018.
  • Amneal Pharmaceuticals' 5-year Receivables Refunds high stood at $29.6 million for Q4 2018, and its period low was $13.7 million during Q4 2019.